{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:10:59Z","timestamp":1793779859286,"version":"4.6.1"},"reference-count":47,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Alterations of SETD2, a histone 3 lysine 36 trimethyl (H3K36me3) transferase leads to resistance to DNA damaging-chemotherapy in leukemia. Low H3K36me3 levels impair DNA damage response and increase mutation rate, which may be targeted by H3K36me3 demethylase inhibition.<\/jats:p>","DOI":"10.1182\/blood-2017-03-775569","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T21:40:17Z","timestamp":1507671617000},"page":"2631-2641","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":129,"title":["SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia"],"prefix":"10.1182","volume":"130","author":[{"given":"Brenton G.","family":"Mar","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Haihua","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine D.","family":"Kahn","sequence":"additional","affiliation":[{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA;"},{"name":"Netherlands Cancer Institute, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei V.","family":"Krivtsov","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Koche","sequence":"additional","affiliation":[{"name":"Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia A.","family":"Castellano","sequence":"additional","affiliation":[{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob L.","family":"Kotlier","sequence":"additional","affiliation":[{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Zon","sequence":"additional","affiliation":[{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"McConkey","sequence":"additional","affiliation":[{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chabon","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Chappell","sequence":"additional","affiliation":[{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Grauman","sequence":"additional","affiliation":[{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Ebert","sequence":"additional","affiliation":[{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111903392111900_B1","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"2019111903392111900_B2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2014-10-551911","article-title":"How I treat refractory and early relapsed acute myeloid leukemia","volume":"126","author":"Thol","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2019111903392111900_B3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MOH.0b013e32834ff4e1","article-title":"Treatment for relapsed acute myeloid leukemia: what is new?","volume":"19","author":"Ofran","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"2019111903392111900_B4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/CCO.0000000000000011","article-title":"Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches","volume":"25","author":"Locatelli","year":"2013","journal-title":"Curr Opin Oncol"},{"issue":"7337","key":"2019111903392111900_B5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"2019111903392111900_B6","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1038\/ncomms4469","article-title":"Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia","volume":"5","author":"Mar","year":"2014","journal-title":"Nat Commun"},{"issue":"3","key":"2019111903392111900_B7","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.18632\/oncotarget.6259","article-title":"Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Xiao","year":"2016","journal-title":"Oncotarget"},{"issue":"42","key":"2019111903392111900_B8","doi-asserted-by":"crossref","first-page":"35261","DOI":"10.1074\/jbc.M504012200","article-title":"Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase","volume":"280","author":"Sun","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"2019111903392111900_B9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The Genetic Basis of Hepatosplenic T-cell Lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"issue":"7380","key":"2019111903392111900_B10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"issue":"35","key":"2019111903392111900_B11","doi-asserted-by":"crossref","first-page":"56746","DOI":"10.18632\/oncotarget.10778","article-title":"Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing","volume":"7","author":"Masetti","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"2019111903392111900_B12","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/leu.2016.134","article-title":"Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia","volume":"30","author":"Parker","year":"2016","journal-title":"Leukemia"},{"issue":"10","key":"2019111903392111900_B13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"issue":"7331","key":"2019111903392111900_B14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma","volume":"469","author":"Varela","year":"2011","journal-title":"Nature"},{"issue":"11","key":"2019111903392111900_B15","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1158\/0008-5472.CAN-10-0120","article-title":"Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma","volume":"70","author":"Duns","year":"2010","journal-title":"Cancer Res"},{"issue":"5","key":"2019111903392111900_B16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-013-1095-8","article-title":"Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas","volume":"125","author":"Fontebasso","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2019111903392111900_B17","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1038\/ncomms4630","article-title":"The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes","volume":"5","author":"Huether","year":"2014","journal-title":"Nat Commun"},{"issue":"5","key":"2019111903392111900_B18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.juro.2016.06.010","article-title":"Prognostic value of SETD2 expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors","volume":"196","author":"Wang","year":"2016","journal-title":"J Urol"},{"issue":"45","key":"2019111903392111900_B19","doi-asserted-by":"crossref","first-page":"e2004","DOI":"10.1097\/MD.0000000000002004","article-title":"Decreased expression of SETD2 predicts unfavorable prognosis in patients with nonmetastatic clear-cell renal cell carcinoma","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2019111903392111900_B20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ng.2894","article-title":"Identification of functional cooperative mutations of SETD2 in human acute leukemia","volume":"46","author":"Zhu","year":"2014","journal-title":"Nat Genet"},{"issue":"9","key":"2019111903392111900_B21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.2951","article-title":"Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing","volume":"32","author":"Heckl","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"7104","key":"2019111903392111900_B22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"issue":"3","key":"2019111903392111900_B23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"issue":"1","key":"2019111903392111900_B24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"2019111903392111900_B25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"3","key":"2019111903392111900_B26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.celrep.2014.10.018","article-title":"Quantitative ChIP-Seq normalization reveals global modulation of the epigenome","volume":"9","author":"Orlando","year":"2014","journal-title":"Cell Reports"},{"issue":"11","key":"2019111903392111900_B27","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1 function leads to EZH2-dependent transformation","volume":"21","author":"LaFave","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"2019111903392111900_B28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nsmb.2796","article-title":"Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks","volume":"21","author":"Aymard","year":"2014","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"2019111903392111900_B29","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.celrep.2014.05.026","article-title":"SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability","volume":"7","author":"Pfister","year":"2014","journal-title":"Cell Reports"},{"key":"2019111903392111900_B30","doi-asserted-by":"crossref","first-page":"e02482","DOI":"10.7554\/eLife.02482","article-title":"SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint","volume":"3","author":"Carvalho","year":"2014","journal-title":"eLife"},{"issue":"3","key":"2019111903392111900_B31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cell.2013.03.025","article-title":"The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutS\u03b1","volume":"153","author":"Li","year":"2013","journal-title":"Cell"},{"issue":"9","key":"2019111903392111900_B32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nsmb.2123","article-title":"Splicing enhances recruitment of methyltransferase HYPB\/Setd2 and methylation of histone H3 Lys36","volume":"18","author":"de Almeida","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"2019111903392111900_B33","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/ncomms3035","article-title":"A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth","volume":"4","author":"Wang","year":"2013","journal-title":"Nat Commun"},{"issue":"5","key":"2019111903392111900_B34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ccell.2015.09.015","article-title":"Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation","volume":"28","author":"Pfister","year":"2015","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111903392111900_B35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/leu.2011.392","article-title":"Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia","volume":"26","author":"Porter","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"2019111903392111900_B36","first-page":"1","article-title":"The role of DNA mismatch repair in drug resistance","volume":"4","author":"Fink","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2019111903392111900_B37","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.AOG.0000239097.42987.0c","article-title":"Improved survival with an intact DNA mismatch repair system in endometrial cancer","volume":"108","author":"Cohn","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2019111903392111900_B38","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.2430","article-title":"Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells","volume":"17","author":"Diouf","year":"2011","journal-title":"Nat Med"},{"issue":"26","key":"2019111903392111900_B39","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"2019111903392111900_B40","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-repair defects and olaparib in metastatic prostate cancer","volume":"373","author":"Mateo","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"2019111903392111900_B41","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1073\/pnas.92.14.6354","article-title":"Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene","volume":"92","author":"Tebbs","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111903392111900_B42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.256214.114","article-title":"Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4","volume":"29","author":"Guillemette","year":"2015","journal-title":"Genes Dev"},{"issue":"7612","key":"2019111903392111900_B43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature18325","article-title":"Replication fork stability confers chemoresistance in BRCA-deficient cells","volume":"535","author":"Ray Chaudhuri","year":"2016","journal-title":"Nature"},{"issue":"7550","key":"2019111903392111900_B44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature14173","article-title":"Differential DNA mismatch repair underlies mutation rate variation across the human genome","volume":"521","author":"Supek","year":"2015","journal-title":"Nature"},{"issue":"7539","key":"2019111903392111900_B45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature14221","article-title":"Cell-of-origin chromatin organization shapes the mutational landscape of cancer","volume":"518","author":"Polak","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2019111903392111900_B46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng.3466","article-title":"Exploring genomic alteration in pediatric cancer using ProteinPaint","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"issue":"D1","key":"2019111903392111900_B47","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/24\/2631\/1404139\/blood775569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/24\/2631\/1404139\/blood775569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:40:07Z","timestamp":1574134807000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/24\/2631\/36872\/SETD2-alterations-impair-DNA-damage-recognition"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":47,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,12,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-03-775569","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]}}}